Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 126

1.

Stability of avoidance behaviour following repeated intermittent treatment with clozapine, olanzapine or D,L-govadine.

Ashby DM, Lapish CC, Phillips AG.

Behav Pharmacol. 2015 Feb;26(1-2):133-8. doi: 10.1097/FBP.0000000000000097.

PMID:
25325293
2.

Distinct neural mechanisms underlying acute and repeated administration of antipsychotic drugs in rat avoidance conditioning.

Li M, Sun T, Zhang C, Hu G.

Psychopharmacology (Berl). 2010 Sep;212(1):45-57. doi: 10.1007/s00213-010-1925-5. Epub 2010 Jul 10.

3.

Repeated asenapine treatment produces a sensitization effect in two preclinical tests of antipsychotic activity.

Qin R, Chen Y, Li M.

Neuropharmacology. 2013 Dec;75:356-64. doi: 10.1016/j.neuropharm.2013.05.031. Epub 2013 Aug 14.

4.

Olanzapine sensitization and clozapine tolerance: from adolescence to adulthood in the conditioned avoidance response model.

Qiao J, Li H, Li M.

Neuropsychopharmacology. 2013 Feb;38(3):513-24. doi: 10.1038/npp.2012.213. Epub 2012 Nov 7.

5.

Avoidance disruptive effect of clozapine and olanzapine is potentiated by increasing the test trials: further test of the motivational salience hypothesis.

Feng M, Sui N, Li M.

Pharmacol Biochem Behav. 2013 Jan;103(3):467-73. doi: 10.1016/j.pbb.2012.09.013. Epub 2012 Sep 28.

6.

Long-term impacts of adolescent risperidone treatment on behavioral responsiveness to olanzapine and clozapine in adulthood.

Qiao J, Zhang Q, Li M.

Prog Neuropsychopharmacol Biol Psychiatry. 2014 Jan 3;48:177-85. doi: 10.1016/j.pnpbp.2013.10.005. Epub 2013 Oct 16.

7.

A preclinical assessment of d.l-govadine as a potential antipsychotic and cognitive enhancer.

Lapish CC, Belardetti F, Ashby DM, Ahn S, Butts KA, So K, Macrae CM, Hynd JJ, Miller JJ, Phillips AG.

Int J Neuropsychopharmacol. 2012 Nov;15(10):1441-55. doi: 10.1017/S146114571100157X. Epub 2011 Nov 10.

PMID:
22071247
8.

Selective effects of D- and L-govadine in preclinical tests of positive, negative, and cognitive symptoms of schizophrenia.

Lapish CC, Ahn KC, Chambers RA, Ashby DM, Ahn S, Phillips AG.

Neuropsychopharmacology. 2014 Jun;39(7):1754-62. doi: 10.1038/npp.2014.23. Epub 2014 Jan 30.

9.
10.

Positive modulation of glutamatergic receptors potentiates the suppressive effects of antipsychotics on conditioned avoidance responding in rats.

Olsen CK, Kreilgaard M, Didriksen M.

Pharmacol Biochem Behav. 2006 Jun;84(2):259-65. Epub 2006 Jun 19.

PMID:
16782180
11.

Repeated effects of the neurotensin receptor agonist PD149163 in three animal tests of antipsychotic activity: assessing for tolerance and cross-tolerance to clozapine.

Chou S, Davis C, Jones S, Li M.

Pharmacol Biochem Behav. 2015 Jan;128:78-88. doi: 10.1016/j.pbb.2014.11.015. Epub 2014 Nov 26.

13.

Effects of D- and L-govadine on the disruption of touchscreen object-location paired associates learning in rats by acute MK-801 treatment.

Lins BR, Phillips AG, Howland JG.

Psychopharmacology (Berl). 2015 Dec;232(23):4371-82. doi: 10.1007/s00213-015-4064-1. Epub 2015 Sep 11.

PMID:
26359226
14.

Dissociable effects of the d- and l- enantiomers of govadine on the disruption of prepulse inhibition by MK-801 and apomorphine in male Long-Evans rats.

Lins BR, Marks WN, Phillips AG, Howland JG.

Psychopharmacology (Berl). 2017 Apr;234(7):1079-1091. doi: 10.1007/s00213-017-4540-x. Epub 2017 Feb 8.

PMID:
28180960
15.

An investigation of the behavioral mechanisms of antipsychotic action using a drug-drug conditioning paradigm.

Li M, He W, Mead A.

Behav Pharmacol. 2009 Mar;20(2):184-94. doi: 10.1097/FBP.0b013e32832a8f66.

17.

Time-dependent sensitization of antipsychotic effect in adolescent male and female rats.

Ding X, Li X, Shu Q, Wu R, Hu G, Li M.

Behav Brain Res. 2017 Jun 15;328:186-194. doi: 10.1016/j.bbr.2017.04.013. Epub 2017 Apr 12.

PMID:
28412306
18.

The effects of d-govadine on conditioned place preference with d-amphetamine or food reward.

Nesbit MO, Dias C, Phillips AG.

Behav Brain Res. 2017 Mar 15;321:223-231. doi: 10.1016/j.bbr.2016.12.043. Epub 2017 Jan 3.

PMID:
28062254
19.

Clozapine, but not olanzapine, disrupts conditioned avoidance response in rats by antagonizing 5-HT2A/2C receptors.

Li M, Sun T, Mead A.

J Neural Transm (Vienna). 2012 Apr;119(4):497-505. doi: 10.1007/s00702-011-0722-6. Epub 2011 Oct 11.

20.

A drug-drug conditioning paradigm reveals multiple antipsychotic-nicotine interactions.

Feng M, Sparkman NL, Sui N, Li M.

J Psychopharmacol. 2017 Apr;31(4):474-486. doi: 10.1177/0269881116681471. Epub 2016 Dec 14.

PMID:
28347260

Supplemental Content

Support Center